Johan Nuyts

Johan Nuyts

Auto-generated profile, based on publicly available information

Johan Nuyts

Nuclear Medicine and Molecular Imaging, KU Leuven, UZ Gasthuisberg, Herestraat 49, Leuven, 3000, BELGIUM

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in The Lancet
Verified
Journal Article
Closed access
SJStefan Janssens
Stefan Janssens
CDChristophe Dubois
Christophe Dubois
JBJan Bogaert
Jan Bogaert
KTKoen Theunissen
Koen Theunissen
CDChristophe M. Deroose
Christophe M. Deroose
FWFrans Van de Werf
Frans Van de Werf

1 September 2003 in European Journal of Cancer
Verified
Journal Article
Closed access
SSS. Stroobants
S. Stroobants
JGJ. Goeminne
J. Goeminne
MSM. Seegers
M. Seegers
SDS. Dimitrijevic
S. Dimitrijevic
PDP. Dupont
P. Dupont
AOA. van Oosterom
A. van Oosterom

6 January 2008 in Nature Genetics
Verified
Journal Article
Open access
PDF file
JAJulian Aragones
Julian Aragones
MSMartin Schneider
Martin Schneider
KGKatie Van Geyte
Katie Van Geyte
PFPeter Fraisl
Peter Fraisl
TDTom Dresselaers
Tom Dresselaers
PCPeter Carmeliet
Peter Carmeliet
HIF prolyl hydroxylases (PHD1–3) are oxygen sensors that regulate the stability of the hypoxia-inducible factors (HIFs) in an oxygen-dependent manner. Here, we show that loss of Phd1 lowers oxygen consumption in skeletal muscle by reprogramming glucose metabolism from oxidative to more anaerobic ATP production through activation of a Pparα pathway. This metabolic adaptation to oxygen conservation impairs oxidative muscle performance in healthy conditions, but it provides acute protection of myofibers against lethal ischemia. Hypoxia tolerance is not due to HIF-dependent angiogenesis, erythropoiesis or vasodilation, but rather to reduced generation of oxidative stress, which allows Phd1-deficient myofibers to preserve mitochondrial respiration. Hypoxia tolerance relies primarily on Hif-2α and was not observed in heterozygous Phd2-deficient or homozygous Phd3-deficient mice. Of medical importance, conditional knockdown of Phd1 also rapidly induces hypoxia tolerance. These findings delineate a new role of Phd1 in hypoxia tolerance and offer new treatment perspectives for disorders characterized by oxidative stress.

1 January 2001 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Closed access
BMB. De Man
B. De Man
JNJ. Nuyts
J. Nuyts
PDP. Dupont
P. Dupont
GMG. Marchal
G. Marchal
PSP. Suetens
P. Suetens
A new iterative maximum-likelihood reconstruction algorithm for X-ray computed tomography is presented. The algorithm prevents beam hardening artifacts by incorporating a polychromatic acquisition model. The continuous spectrum of the X-ray tube is modeled as a number of discrete energies. The energy dependence of the attenuation is taken into account by decomposing the linear attenuation coefficient into a photoelectric component and a Compton scatter component. The relative weight of these components is constrained based on prior material assumptions. Excellent results are obtained for simulations and for phantom measurements. Beam-hardening artifacts are effectively eliminated. The relation with existing algorithms is discussed. The results confirm that improving the acquisition model assumed by the reconstruction algorithm results in reduced artifacts. Preliminary results indicate that metal artifact reduction is a very promising application for this new algorithm.

1 May 1999 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Closed access
JNJ. Nuyts
J. Nuyts
PDP. Dupont
P. Dupont
SSS. Stroobants
S. Stroobants
RBR. Benninck
R. Benninck
LML. Mortelmans
L. Mortelmans
PSP. Suetens
P. Suetens
In order to perform attenuation correction in emission tomography an attenuation map is required. We propose a new method to compute this map directly from the emission sinogram, eliminating the transmission scan from the acquisition protocol. The problem is formulated as an optimization task where the objective function is a combination of the likelihood and an a priori probability. The latter uses a Gibbs prior distribution to encourage local smoothness and a multimodal distribution for the attenuation coefficients. Since the attenuation process is different in positron emission tomography (PET) and single photon emission tomography (SPECT), a separate algorithm for each case is derived. The method has been tested on mathematical phantoms and on a few clinical studies. For PET, good agreement was found between the images obtained with transmission measurements and those produced by the new algorithm in an abdominal study. For SPECT, promising simulation results have been obtained for nonhomogeneous attenuation due to the presence of the lungs.

22 October 2020 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
PDF file
PLPaul LECOQ
Paul LECOQ
CMChristian Morel
Christian Morel
John PriorJohn Prior
John Prior
DVDimitris Visvikis
Dimitris Visvikis
SGStefan Gundacker
Stefan Gundacker
MBMathieu Benoit
Mathieu Benoit
Since the seventies, positron emission tomography (PET) has become an invaluable medical molecular imaging modality with an unprecedented sensitivity at the picomolar level, especially for cancer diagnosis and the monitoring of its response to therapy. More recently, its combination with x-ray computed tomography (CT) or magnetic resonance (MR) has added high precision anatomic information in fused PET/CT and PET/MR images, thus compensating for the modest intrinsic spatial resolution of PET. Nevertheless, a number of medical challenges call for further improvements in PET sensitivity. These concern in particular new treatment opportunities in the context personalized (also called precision) medicine, such as the need to dynamically track a small number of cells in cancer immunotherapy or stem cells for tissue repair procedures. A better signal-to-noise ratio (SNR) in the image would allow detecting smaller size tumours together with a better staging of the patients, thus increasing the chances of putting cancer in complete remission. Moreover, there is an increasing demand for reducing the radioactive doses injected to the patients without impairing image quality. There are three ways to improve PET scanner sensitivity: improving detector efficiency, increasing geometrical acceptance of the imaging device and pushing the timing performance of the detectors. Currently, some pre-localization of the electron-positron annihilation along a line-of-response (LOR) given by the detection of a pair of annihilation photons is provided by the detection of the time difference between the two photons, also known as the time-of-flight (TOF) difference of the photons, whose accuracy is given by the coincidence time resolution (CTR). A CTR of about 10 picoseconds FWHM will ultimately allow to obtain a direct 3D volume representation of the activity distribution of a positron emitting radiopharmaceutical, at the millimetre level, thus introducing a quantum leap in PET imaging and quantification and fostering more frequent use of 11 C radiopharmaceuticals. The present roadmap article toward the advent of 10 ps TOF-PET addresses the status and current/future challenges along the development of TOF-PET with the objective to reach this mythic 10 ps frontier that will open the door to real-time volume imaging virtually without tomographic inversion. The medical impact and prospects to achieve this technological revolution from the detection and image reconstruction point-of-views, together with a few perspectives beyond the TOF-PET application are discussed.